StockData
Novartis AG logo

Novartis AG (NVS) stock

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$155.21−3.92 (-2.46%)

Close on Nov 18, 2026Market cap $296.16BP/E 21.7Yield –

Novartis total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Novartis's total debt was $1.48B at Dec 31, 2025. For fiscal 2025 it was $1.48B, down 63.1% from the year before. The highest annual figure on record is $4.00B in fiscal 2024.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.48B-63.1%
FY2024Dec 31, 2024$4.00B+42.0%
FY2023Dec 31, 2023$2.82B-9.3%
FY2022Dec 31, 2022$3.10B-11.8%
FY2021Dec 31, 2021$3.52B+8.4%
FY2020Dec 31, 2020$3.25B+19.4%
FY2019Dec 31, 2019$2.72B-30.1%
FY2018Dec 31, 2018$3.89B+270.2%
FY2017Dec 31, 2017$1.05B+3.6%
FY2016Dec 31, 2016$1.01B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$1.48B-58.1%
Q4 FY2024Dec 31, 2024$4.00B+23.1%
Q4 FY2023Dec 31, 2023$2.82B+3.5%
Q4 FY2022Dec 31, 2022$3.10B-20.2%
Q4 FY2021Dec 31, 2021$3.52B+234.9%
Q4 FY2020Dec 31, 2020$3.25B+220.3%
Q4 FY2019Dec 31, 2019$2.72B–
Q4 FY2018Dec 31, 2018$3.89B–
Q4 FY2017Dec 31, 2017$1.05B–
Q4 FY2016Dec 31, 2016$1.01B–

More Novartis figures

See a number that looks wrong?